Danaher in partnership with AstraZeneca for diagnostic tests for precision medicine

21 hours ago 1

Danaher (NYSE:DHR) has inked an agreement with AstraZeneca (NASDAQ:AZN) to develop diagnostic tests and tools that will help doctors determine which precision medicine treatments are best for individual patients.
The first product envisioned for development will use technologies from Leica

Recommended For You